vs
Side-by-side financial comparison of BioRestorative Therapies, Inc. (BRTX) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.
CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $19.6K, roughly 400.2× BioRestorative Therapies, Inc.). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -16365.5%, a 16316.8% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -54.7%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-2.5M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -25.2%).
BioRestorative Therapies, Inc. is a clinical-stage biotechnology company focused on developing innovative regenerative medicine therapies. Its core pipeline includes candidate treatments for chronic lower back pain, metabolic disorders and other unmet medical needs, primarily serving markets in North America as it advances novel cell-based therapeutic candidates through clinical trials.
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
BRTX vs CCEL — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $19.6K | $7.8M |
| Net Profit | $-3.2M | $-3.8M |
| Gross Margin | 91.7% | 77.9% |
| Operating Margin | -19516.8% | -50.6% |
| Net Margin | -16365.5% | -48.7% |
| Revenue YoY | -54.7% | -2.3% |
| Net Profit YoY | -96.0% | -105.1% |
| EPS (diluted) | $-0.31 | $-0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.6K | $7.8M | ||
| Q3 25 | $11.8K | $7.8M | ||
| Q2 25 | $303.3K | $7.9M | ||
| Q1 25 | $25.0K | $8.0M | ||
| Q4 24 | $43.3K | $8.0M | ||
| Q3 24 | $233.6K | $8.1M | ||
| Q2 24 | $89.1K | $8.0M | ||
| Q1 24 | $35.0K | $7.9M |
| Q4 25 | $-3.2M | $-3.8M | ||
| Q3 25 | $-3.0M | $749.4K | ||
| Q2 25 | $-2.7M | $355.8K | ||
| Q1 25 | $-5.3M | $282.9K | ||
| Q4 24 | $-1.6M | $-1.9M | ||
| Q3 24 | $-1.1M | $1.1M | ||
| Q2 24 | $-4.0M | $655.8K | ||
| Q1 24 | $-2.2M | $556.2K |
| Q4 25 | 91.7% | 77.9% | ||
| Q3 25 | 10.4% | 77.0% | ||
| Q2 25 | 97.1% | 76.6% | ||
| Q1 25 | 88.4% | 75.1% | ||
| Q4 24 | 92.3% | 78.4% | ||
| Q3 24 | 92.2% | 73.6% | ||
| Q2 24 | 92.7% | 74.8% | ||
| Q1 24 | 100.0% | 73.7% |
| Q4 25 | -19516.8% | -50.6% | ||
| Q3 25 | -31432.3% | 24.3% | ||
| Q2 25 | -1089.8% | 18.8% | ||
| Q1 25 | -19230.1% | 13.3% | ||
| Q4 24 | -6212.8% | -1.5% | ||
| Q3 24 | -979.0% | 17.2% | ||
| Q2 24 | -2770.8% | 17.3% | ||
| Q1 24 | -11740.7% | 10.5% |
| Q4 25 | -16365.5% | -48.7% | ||
| Q3 25 | -25748.1% | 9.6% | ||
| Q2 25 | -875.8% | 4.5% | ||
| Q1 25 | -21359.2% | 3.5% | ||
| Q4 24 | -3778.6% | -23.2% | ||
| Q3 24 | -467.2% | 13.0% | ||
| Q2 24 | -4521.4% | 8.2% | ||
| Q1 24 | -6352.2% | 7.1% |
| Q4 25 | $-0.31 | $-0.46 | ||
| Q3 25 | $-0.33 | $0.09 | ||
| Q2 25 | $-0.30 | $0.04 | ||
| Q1 25 | $-0.64 | $0.03 | ||
| Q4 24 | $-0.20 | $-0.23 | ||
| Q3 24 | $-0.13 | $0.13 | ||
| Q2 24 | $-0.50 | $0.08 | ||
| Q1 24 | $-0.33 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $3.3M |
| Total DebtLower is stronger | — | $8.4M |
| Stockholders' EquityBook value | $356.7K | $-18.6M |
| Total Assets | $4.1M | $61.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $3.3M | ||
| Q3 25 | $4.5M | $3.2M | ||
| Q2 25 | $7.4M | $4.4M | ||
| Q1 25 | $9.1M | $3.5M | ||
| Q4 24 | $10.7M | $3.5M | ||
| Q3 24 | $13.1M | $2.1M | ||
| Q2 24 | $14.7M | $1.5M | ||
| Q1 24 | $16.4M | $979.6K |
| Q4 25 | — | $8.4M | ||
| Q3 25 | — | $8.4M | ||
| Q2 25 | — | $8.4M | ||
| Q1 25 | — | $8.5M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $8.5M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | $356.7K | $-18.6M | ||
| Q3 25 | $2.2M | $-14.8M | ||
| Q2 25 | $4.8M | $-15.6M | ||
| Q1 25 | $6.1M | $-14.7M | ||
| Q4 24 | $8.5M | $-13.2M | ||
| Q3 24 | $10.0M | $-9.6M | ||
| Q2 24 | $10.8M | $-10.7M | ||
| Q1 24 | $14.5M | $-10.3M |
| Q4 25 | $4.1M | $61.7M | ||
| Q3 25 | $5.6M | $63.2M | ||
| Q2 25 | $8.5M | $64.4M | ||
| Q1 25 | $10.3M | $64.4M | ||
| Q4 24 | $12.3M | $64.7M | ||
| Q3 24 | $14.6M | $62.9M | ||
| Q2 24 | $16.1M | $62.6M | ||
| Q1 24 | $18.0M | $61.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.4M | $1.3M |
| Free Cash FlowOCF − Capex | $-2.5M | $1.2M |
| FCF MarginFCF / Revenue | -12728.8% | 15.5% |
| Capex IntensityCapex / Revenue | 406.5% | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.4M | $1.3M | ||
| Q3 25 | $-2.9M | $2.5M | ||
| Q2 25 | $-2.7M | $707.0K | ||
| Q1 25 | $-2.8M | $954.1K | ||
| Q4 24 | $-2.3M | $2.2M | ||
| Q3 24 | $-1.7M | $2.4M | ||
| Q2 24 | $-1.9M | $1.8M | ||
| Q1 24 | $-2.3M | $-356.9K |
| Q4 25 | $-2.5M | $1.2M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $644.6K | ||
| Q1 25 | $-2.8M | $892.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-1.8M | $2.3M | ||
| Q2 24 | — | $21.5K | ||
| Q1 24 | — | $-814.6K |
| Q4 25 | -12728.8% | 15.5% | ||
| Q3 25 | — | 31.9% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | -11260.7% | 11.2% | ||
| Q4 24 | — | 26.8% | ||
| Q3 24 | -752.6% | 27.9% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | -10.4% |
| Q4 25 | 406.5% | 0.9% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 145.6% | 0.8% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 25.0% | 2.3% | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | 5.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.38× | ||
| Q2 25 | — | 1.99× | ||
| Q1 25 | — | 3.37× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.32× | ||
| Q2 24 | — | 2.70× | ||
| Q1 24 | — | -0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
